GNOLF.OTC.PinkGenoil INC

20-F: Genoil Inc. Files Annual Report on Form 20-F

Sentiment:

Annual Report


Genoil Inc. has filed its annual report on Form 20-F for the fiscal years ended December 31, 2025, 2024, and 2023, detailing its financial status, operational review, and risk factors.

Capital raiseDuring the year ended December 31, 2025, the Company issued 43,375,000 shares of common stock (and warrants) in private placements for total net proceeds of $402,500.During the year ended December 31, 2024, the Company sold a total of 15,730,000 shares of common stock (and warrants) in private placements for total proceeds of $157,300.During the year ended December 31, 2024, the Company sold a total of 14,390,000 shares of common stock (and warrants) in private placements for total proceeds of $143,800.During the year ended December 31, 2024, the Company sold a total of 16,610,000 shares of common stock (and warrants) in private placements for total proceeds of $166,100.During the year ended December 31, 2024, the Company sold a total of 8,265,000 shares of common stock (and warrants) in private placements for total proceeds of $75,650.During the year ended December 31, 2023, the Company sold a total of 11,800,000 shares of common stock (and warrants) in private placements for total proceeds of $118,000.During the year ended December 31, 2023, the Company sold a total of 12,520,000 shares of common stock (and warrants) in private placements for total proceeds of $125,200.During the year ended December 31, 2023, the Company sold a total of 12,960,000 shares of common stock (and warrants) in private placements for total proceeds of $129,600.During the year ended December 31, 2023, the Company sold a total of 27,850,000 shares of common stock (and warrants) in private placements for total proceeds of $278,500.Management plans to seek additional financing through private placements or other equity financing transactions.
Worse than expectedThe company continues to report significant operating losses and negative cash flows from operations.The company's ability to continue as a going concern is dependent on its success in commercializing its technologies and securing financing, with substantial doubt remaining.Material weaknesses in internal controls over financial reporting have been identified, including insufficient segregation of duties and a lack of technical accounting expertise.The company's cash and cash equivalents were only $12 as of December 31, 2025, indicating severe liquidity constraints.

Summary

  • Genoil Inc. has filed its annual report on Form 20-F for the fiscal years ending December 31, 2025, 2024, and 2023.
  • The company continues to focus on the development and commercialization of its proprietary hydrocarbon processing and upgrading technologies, particularly the Genoil Hydroconversion Upgrader (GHU).
  • Genoil has not yet achieved commercially viable operations from its patents and technology rights, leading to ongoing operating losses and negative cash flows.
  • The company's ability to continue as a going concern is dependent on its success in commercializing its technologies, achieving profitability, and securing necessary financing.
  • Management believes that existing cash resources, combined with the historical ability to raise additional capital through equity financings, will be sufficient to fund planned operations for the next twelve months.
  • The report details significant potential dilution from outstanding warrants, options, and convertible debt.
  • Genoil has no material operating activities that generate significant greenhouse gas emissions and therefore does not report Scope 1, 2, or 3 emissions.
  • The company's common stock is quoted on the OTC Markets under the symbol GNOLF.
  • No cash compensation is paid to executives or board members; they receive shares, options, or Price Appreciation Certificates.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as negative due to the company's continued operating losses, lack of commercial operations, substantial accumulated deficit, and material weaknesses in internal controls, despite management's plans to secure future financing.

Positives

  • Management expresses confidence in its ability to secure necessary financing through equity issuances, citing a demonstrated history of successful capital raises.
  • The company has a joint venture, Genoil Emirates LLC, in the UAE to develop projects for its technologies.
  • Genoil has secured several US and Canadian patents for its technologies.
  • The GHU technology is claimed to remove 99.5% of sulfur and increase light oil production by 54% by converting residue.
  • The company has a plan to address its going concern status through financing and business initiatives.
  • The company has a new auditor, HHL LLP, appointed in December 2024.

Negatives

  • Genoil has incurred substantial operating losses and negative cash flows since inception and expects these to continue.
  • The company has not attained commercially viable operations from its patents and technology rights.
  • The ability to continue as a going concern is dependent on commercializing technologies, achieving profitability, and obtaining financing.
  • There is a material weakness in internal controls due to insufficient segregation of duties and ineffective supervision and monitoring.
  • Management concluded that the company's internal controls over financial reporting were not effective due to a lack of sufficient technical accounting knowledge regarding income taxes and complex financial instruments.
  • The company has a significant accumulated deficit of $106,563,227 as of December 31, 2025.
  • The company has no formal insider trading policies or cybersecurity processes due to its small personnel size and limited resources.
  • The company has not formally adopted insider trading policies due to the intimate composition of its personnel.

Risks

  • The company has a history of substantial losses and negative cash flows, and expects these to continue, potentially impacting its ability to operate.
  • Commercializing its technologies requires significant financial resources, and future revenues may not be sufficient to fund development and marketing.
  • Genoil is dependent on external financing, which may not be available on acceptable terms.
  • The company's intellectual property and technology may not perform as anticipated or may be surpassed by new technologies.
  • Market acceptance of Genoil's technologies is uncertain, and the market may not develop as anticipated.
  • Key contractors or senior management could terminate their engagements, hindering development and operations.
  • The potential exercise of outstanding warrants, options, and convertible debt could significantly dilute earnings per share.
  • Genoil may face claims of infringing proprietary rights of others.
  • The company may not be able to adequately protect its proprietary information.
  • Competitors may have greater financial and marketing resources.
  • Acquisitions, if pursued, carry risks of integration challenges, diversion of management attention, and financial strain.
  • U.S. investors may face difficulties enforcing judgments against Genoil or its management due to its Canadian incorporation and asset location.
  • It is undetermined how climate change may affect Genoil's business affairs, though currently it has no material operating activities generating greenhouse gas emissions.

Future Outlook

Genoil expects to continue incurring operating losses in the near term and plans to fund operations through capital stock offerings and project loans. Management believes that existing cash resources, combined with the historical ability and ongoing expectation to raise additional capital through equity financings, will be sufficient to fund planned operations and meet obligations for the twelve-month period following the issuance date of the financial statements. The company will continue to review prospects for raising additional debt and equity financing to support operations until they become self-sustaining.

Management Comments

  • Management has evaluated the Company's expected cash requirements for the twelve-month period following the issuance date of these financial statements and believes that existing cash resources, together with the Company's historical ability and ongoing expectation to raise additional capital through equity financings, will be sufficient to fund planned operations and meet the Company's obligations as they become due.
  • Management expects to continue accessing capital through existing and prospective investors as needed to support operations while continuing efforts to execute contracts and business initiatives intended to generate future revenues, cash flows, and profitability.
  • Management continues to monitor climate-related regulation and disclosure requirements; however, given the absence of operating activity, the financial and operational impacts of climate change on the Company's business affairs for this period are not material.
  • Due to the intimate nature of the Company, its limited resources and the assessed minimal risk of such an occurrence, the Company has no formal processes for assessing, identifying, and managing material risks from cybersecurity threats.

Industry Context

StockSavvy.ai notes that Genoil Inc.'s filing highlights the challenges faced by early-stage technology development companies in the oil and gas sector, particularly those reliant on intellectual property commercialization. The company's focus on upgrading heavy crude and separating oil from water aligns with industry trends towards maximizing resource utilization and meeting stricter environmental regulations, but its lack of commercial operations and ongoing losses are significant hurdles.

Comparison to Industry Standards

  • Genoil's reported net loss of $640,501 for 2025 and $2,086,303 for 2024, coupled with a significant accumulated deficit, contrasts sharply with established players in the oil and gas technology sector who typically report substantial revenues and profits from commercialized operations.
  • The company's reliance on equity financings for survival is common among startups but differs from mature companies that may utilize debt financing or retained earnings for operations and expansion.
  • While Genoil claims its GHU technology can remove 99.5% of sulfur, industry benchmarks for advanced desulfurization processes vary, with many commercial operations achieving high removal rates but often requiring significant capital investment and operational scale.
  • The company's lack of greenhouse gas emissions due to no commercial operations is a stark contrast to larger energy companies that are increasingly disclosing their emissions profiles and investing in decarbonization strategies.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Internal ControlsMaterial weakness identified in internal controls over financial reporting due to insufficient segregation of duties and lack of technical accounting knowledge.2025-12-31Reasonable possibility that material misstatements of financial statements will not be prevented or detected on a timely basis.
Audit Committee CompositionAudit Committee consists of Thomas F. Bugg and David Lifschultz. One member is a related party.OngoingPotential for reduced independent oversight of financial reporting.
Insider Trading PoliciesRegistrant has not formally adopted insider trading policies and procedures.OngoingIncreased risk of non-compliance with insider trading laws and regulations.
Cybersecurity ProcessesCompany has no formal processes for assessing, identifying, and managing material risks from cybersecurity threats.OngoingVulnerability to cybersecurity threats due to lack of formal risk management.

Related Party Transactions

  • Convertible notes to Lifschultz Enterprise Company LLC with principal balance of $220,139 and accrued interest of $72,256 as of December 31, 2025.
  • The notes bear 12% interest and have been extended to January 1, 2028, with an inflation protection provision.
  • Related party payables include $102,467 to Lifschultz Enterprise Company LLC as of December 31, 2025, including $55,592 for living expenses of an executive.
  • David Lifschultz and Bruce Abbott, CEO and COO respectively, have not received cash compensation, only share-based awards (Price Appreciation Certificates and options).

Stakeholder Impact

  • Shareholders face significant dilution risk from outstanding warrants, options, and convertible debt, and the company's continued losses and going concern issues pose a risk to their investment.
  • Employees and consultants may receive compensation in the form of stock-based awards, aligning their interests with shareholders but also exposing them to the company's stock price volatility.
  • Creditors and suppliers may face risks due to the company's precarious financial position and ongoing losses, although no material defaults have been reported.
  • Management's compensation is tied to share performance through stock-based awards, creating an incentive to increase shareholder value, but also highlighting the lack of cash compensation.

Next Steps

  • Continue efforts to execute contracts and business initiatives intended to generate future revenues, cash flows, and profitability.
  • Seek additional financing through private placements or other equity financing transactions.
  • Continue to monitor climate-related regulation and disclosure requirements.
  • Reassess climate-related risks and opportunities and provide appropriate disclosures should the Company recommence or expand operations.

Key Dates

DateDescription
1996-09-05Company created from an amalgamation under the Canada Business Corporations Act.
2001-01-01David Lifschultz has headed Genoil as CEO since this approximate period.
2006-05-31Shareholders authorized the creation of Class A Preferred Shares and appointment of additional directors.
2016-11-14Special resolution passed authorizing the continuance of the Corporation from Canada to Curaçao (though not yet implemented).
2019-05-29Company received a letter of satisfaction from Corporations Canada approving the move to Curacao (not yet implemented).
2024-12-26HHL LLP appointed as the new independent registered public accounting firm.
2025-01-01Principal balance and accrued interest due to Lifschultz Enterprise Company LLC extended to this date.
2025-12-31Fiscal year end for which financial statements are reported.
2026-01-01Maturity date for convertible notes to Lifschultz Enterprise Company LLC, extended to January 1, 2028.
2026-05-11Date of the report and the date through which subsequent events were evaluated.
2026-05-12Date of CEO certifications under Sarbanes-Oxley Act.

Recommendation

sell

The company continues to operate at a significant loss, has not achieved commercial viability, faces substantial doubt regarding its ability to continue as a going concern, and has identified material weaknesses in its internal controls. While management plans to seek further financing, the ongoing financial distress and operational challenges present a high risk to investors.

Keywords

Genoil Inc., Form 20-F, Annual Report, Oil and Gas Technology, Hydrocarbon Processing, Upgrading Technology, GHU, Financial Statements, Going Concern, Capital Raise, Intellectual Property, OTC Markets, GNOLF

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.